Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Death receptors in chemotherapy and cancer

Abstract

Apoptosis, the cell's intrinsic death program, is a key regulator of tissue homeostasis. An imbalance between cell death and proliferation may result in tumor formation. Also, killing of cancer cells by cytotoxic therapies such as chemotherapy, γ-irradiation or ligation of death receptors is predominantly mediated by triggering apoptosis in target cells. In addition to the intrinsic mitochondrial pathway, elements of death receptor signaling pathways have been implied to contribute to the efficacy of cancer therapy. Failure to undergo apoptosis in response to anticancer therapy may lead to resistance. Also, deregulated expression of death receptor pathway molecules may contribute to tumorigenesis and tumor escape from endogenous growth control. Understanding the molecular events that regulate apoptosis induced by anticancer therapy and how cancer cells evade apoptosis may provide new opportunities for pathway-based rational therapy and for drug development.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M and Altieri DC . (1998). Lancet, 351, 882–883.

  • Adrain C and Martin SJ . (2001). Trends Biochem. Sci., 26, 390–397.

  • Adida C, Recher C, Raffoux E, Daniel MT, Taksin AL, Rousselot P, Sigaux F, Degos L, Altieri DC and Dombret H . (2000). Br. J. Haematol., 111, 196–203.

  • Algeciras-Schimnich A, Pietras EM, Barnhart BC, Legembre P, Vijayan S, Holbeck SL and Peter ME . (2003). Proc. Natl. Acad. Sci. USA, 100, 11445–11450.

  • Allison J, Georgiou HM, Strasser A and Vaux DL . (1997). Proc. Natl. Acad. Sci. USA, 94, 3943–3947.

  • Altieri DC . (2001). Trends Mol. Med., 7, 542–547.

  • Altieri DC . (2003a). Nat. Rev. Cancer, 3, 46–54.

  • Altieri DC . (2003b). Adv. Cancer Res., 88, 31–52.

  • Apolinario RM, van-der-Valk P, de Jong JS, Deville W, van-Ark-Otte J, Dingemans AM, van Mourik JC, Postmus PE, Pinedo HM and Giaccone G . (1997). J. Clin. Oncol., 15, 2456–2466.

  • Arai H, Gordon D, Nabel EG and Nabel GJ . (1997). Proc. Natl. Acad. Sci. USA, 94, 13862–13867.

  • Arnt CR, Chiorean MV, Heldebrant MP, Gores GJ and Kaufmann SH . (2002). J. Biol. Chem., 277, 44236–44243.

  • Ashkenazi A and Dixit VM . (1998). Science, 281, 1305–1308.

  • Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH . (1999). J. Clin. Invest., 104, 155–162.

  • Baghdassarian N, Bertrand Y, Gerland LM, French P, Duhaut P, Bryon PA, Magaud JM and Ffrench M . (2001). Leukemia Lymphoma, 42, 1067–1075.

  • Banerjee D . (2001). Curr. –Opin. Invest. Drugs, 2, 574–580.

  • Bargou RC, Daniel PT, Mapara MY, Bommert K, Wagener C, Kallinich B, Royer HD and Dorken B . (1995). Int. J. Cancer, 60, 854–859.

  • Baylin S and Bestor TH . (2002). Cancer Cell, 1, 299–305.

  • Behrens CK, Igney FH, Arnold B, Moller P and Krammer PH . (2001). J. Immunol., 166, 3240–3247.

  • Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H, Bamberg M, Schulze-Osthoff K and Budach W . (2001). Oncogene, 20, 2190–2196.

  • Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A and Duke RC . (1995). Nature, 377, 630–632.

  • Beltinger C, Fulda S, Kammertoens T, Meyer E, Uckert W and Debatin KM . (1999). Proc. Natl. Acad. Sci. USA, 96, 8699–8704.

  • Beltinger CP, Kurz E, Böhler T, Schrappe M, Ludwig WD and Debatin K-M . (1998). Blood, 91, 3943–3951.

  • Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK and Shanahan F . (1998). J. Immunol., 160, 5669–5675.

  • Borner C and Monney L . (1999). Cell Death Differ., 6, 497–507.

  • Boudard D, Vasselon C, Bertheas MF, Jaubert J, Mounier C, Reynaud J, Viallet A, Chautard S, Guyotat D and Campos L . (2002). Am. J. Hematol., 70, 115–125.

  • Bratton SB, MacFarlane M, Cain K and Cohen GM . (2000). Exp. Cell Res., 256, 27–33.

  • Budihardjo I, Oliver H, Lutter M, Luo X and Wang X . (1999). Annu. Rev. Cell. Dev. Biol., 15, 269–290.

  • Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud JP and Guyotat D . (1993). Blood, 81, 3091–3096.

  • Campos L, Sabido O, Sebban C, Charrin C, Bertheas MF, Fiere D and Guyotat D . (1996). Leukemia, 10, 434–438.

  • Campos L, Sabido O, Viallet A, Vasselon C and Guyotat D . (1999). Leukemia Lymphoma, 33, 499–509.

  • Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J and Hood L . (1997). Immunity, 7, 821–830.

  • Chen Y, Sato M, Fujimura S, Endo C, Sakurada A, Aikawa H, Takahashi H, Tanita T, Kondo T, Saito Y and Sagawa M . (1999). Anticancer Res., 19, 1351–1356.

  • Cheok MH, Yang W, Pui C-H, Downing JR, Cheng Ch., Naeve CW, Relling MV and Evans WE . (2003). Nat. Gen., 34, 85.

  • Chi KN, Gleave ME, Klasa R, Murray N, Bryce C, Lopes-de-Menezes DE, D'Aloisio S and Tolcher AW . (2001). Clin. Cancer Res., 7, 3920–3927.

  • Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD and Rehemtulla A . (2000). Proc. Natl. Acad. Sci. USA, 97, 1754–1759.

  • Chuntharapai A, Dodge K, Grimmer K, Schroeder K, Marsters SA, Koeppen H, Ashkenazi A and Kim KJ . (2001). J. Immunol., 166, 4891–4898.

  • Colomo L, Lopez-Guillermo A, Perales M, Rives S, Martinez A, Bosch F, Colomer D, Falini B, Montserrat E and Campo E . (2003). Blood, 101, 78–84.

  • Cotter FE, Johnson P, Hall P, Pocock C, al-Mahdi N, Cowell JK and Morgan G . (1994). Oncogene, 9, 3049–3055.

  • Coustan-Smith E, Kitanaka A, Pui CH, McNinch L, Evans WE, Raimondi SC, Behm FG, Arico M and Campana D . (1996). Blood, 87, 1140–1146.

  • Cowling V and Downward J . (2002). Cell Death Differ., 9, 1046–1056.

  • Datta R, Oki E, Endo K, Biedermann V, Ren J and Kufe D . (2000). J. Biol. Chem., 275, 31733–31738.

  • Davis RJ . (2000). Cell, 103, 239–252.

  • Debatin KM . (1997). J. Natl. Cancer Inst., 89, 750–753.

  • Debatin KM . (1999). The Role of the CD95 System in Chemotherapy, Broxterman HJA (ed). Churchill Livingstone: Edinburgh, pp. 85–90.

    Google Scholar 

  • Debatin KM, Poncet D and Kroemer G . (2002). Oncogene, 21, 8786–8803.

  • Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA and Goodwin RG . (1997a). Immunity, 7, 813–820.

  • Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG and Smith CA . (1997b). J. Exp. Med., 186, 1165–1170.

  • Del Poeta G, Venditti A, Del Principe MI, Maurillo L, Buccisano F, Tamburini A, Cox MC, Franchi A, Bruno A, Mazzone C, Panetta P, Suppo G, Masi M and Amadori S . (2003). Blood, 101, 2125–2131.

  • Droin N, Dubrez L, Eymin B, Renvoize C, Breard J, Dimanche-Boitrel MT and Solary E . (1998). Oncogene, 16, 2885–2894.

  • Du C, Fang M, Li Y, Li L and Wang X . (2000). Cell, 102, 33–42.

  • Earnshaw WC, Martins LM and Kaufmann SH . (1999). Annu. Rev. Biochem., 68, 383–424.

  • Eichhorst ST, Muerkoster S, Weigand MA and Krammer PH . (2001). Cancer Res., 61, 243–248.

  • Eichhorst ST, Muller M, Li-Weber M, Schulze-Bergkamen H, Angel P and Krammer PH . (2000). Mol. Cell. Biol., 20, 7826–7837.

  • Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ and Kaufmann SH . (1997). Blood, 90, 935–943.

  • El-Deiry WS . (2001). Cell Death Differ., 8, 1066–1075.

  • Elnemri A, Ohta T, Yachie A, Kayahara M, Kitagawa H, Fujimura T, Ninomiya I, Fushida S, Nishimura GI, Shimizu K and Miwa K . (2001). Int. J. Oncol., 18, 311–316.

  • Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, James IE, Rosenberg M, Lee JC and Young PR . (1998). J. Biol. Chem., 273, 14363–14367.

  • Erhardt H, Fulda S, Schmid I, Hiscott J, Debatin KM and Jeremias I . (2003). Oncogene, 22, 3842–3852.

  • Estrov Z, Thall PF, Talpaz M, Estey EH, Kantarjian HM, Andreeff M, Harris D, Van Q, Walterscheid M and Kornblau SM . (1998). Blood, 92, 3090–3097.

  • Ferri KF and Kroemer G . (2000). Nat. Cell Biol., 2, E63–64.

  • Finkel E . (1999). Science, 286, 2256–2258.

  • French LE and Tschopp J . (1999). J. Exp. Med., 190, 891–894.

  • French LE and Tschopp J . (2002). Cancer Biol., 12, 51–55.

  • Friesen C, Fulda S and Debatin KM . (1997). Leukemia, 11, 1833–1841.

  • Friesen C, Fulda S and Debatin KM . (1999). Cell Death Differ., 6, 471–480.

  • Friesen C, Herr I, Krammer PH and Debatin KM . (1996). Nat. Med., 2, 574–577.

  • Fulda S and Debatin KM . (2002). Oncogene, 21, 2295–2308.

  • Fulda S, Friesen C, Los M, Scaffidi CA, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME and Debatin KM . (1997a). Cancer Res., 57, 4956–4964.

  • Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B and Debatin KM . (2001). Oncogene, 20, 5865–5877.

  • Fulda S, Los M, Friesen C and Debatin KM . (1998a). Int. J. Cancer, 76, 105–114.

  • Fulda S, Meyer E and Debatin KM . (2000a). Cancer Res., 60, 3947–3956.

  • Fulda S, Meyer E, Susin SA, Kroemer G and Debatin KM . (2000b). Oncogene, 20, 1063–1075.

  • Fulda S, Scaffidi C, Pietsch T, Krammer PH, Peter ME and Debatin KM . (1998b). Cell Death Differ., 5, 884–893.

  • Fulda S, Sieverts H, Friesen C, Herr I and Debatin KM . (1997b). Cancer Res., 7, 3823–3829.

  • Fulda S, Strauss G, Meyer E and Debatin KM . (2000c). Blood, 95, 301–308.

  • Fulda S, Susin SA, Kroemer G and Debatin KM . (1998c). Cancer Res., 58, 4453–4460.

  • Fulda S, Wick W, Weller M and Debatin KM . (2002). Nat. Med., 8, 808–815.

  • Gala JL, Vermylen C, Cornu G, Ferrant A, Michaux JL, Philippe M and Martiat P . (1994). Ann. Hematol., 69, 17–24.

  • Gascoyne RD, Adomat SA, Krajewski S, Krajewska M, Horsman DE, Tolcher AW, O'Reilly SE, Hoskins P, Coldman AJ, Reed JC and Connors JM . (1997a). Blood, 90, 244–251.

  • Gascoyne RD, Krajewska M, Krajewski S, Connors JM and Reed JC . (1997b). Blood, 90, 3173–3178.

  • Gessner C, Liebers U, Kuhn H, Stiehl P, Witt C, Schauer J and Wolff G . (2002). Eur. Respir. J., 19, 134–140.

  • Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K and Koukourakis MI . (2001). Anticancer Res., 21, 253–259.

  • Glaser T, Wagenknecht B, Groscurth P, Krammer PH and Weller M . (1999). Oncogene, 18, 5044–5053.

  • Gliniak B and Le T . (1999). Cancer Res., 59, 6153–6158.

  • Golub TR . (2003). Nat. Med., 9, 510.

  • Green DR and Ferguson TA . (2001). Nat. Rev. Mol. Cell. Biol., 2, 917–924.

  • Griffith TS, Brunner T, Fletcher SM, Green DR and Ferguson TA . (1995). Science, 270, 1189–1192.

  • Gronbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE, Zeuthen J, Hou-Jensen K and Guldberg P . (1998). Blood, 92, 3018–3024.

  • Guo F, Nimmanapalli R, Paranawithana S, Wittman S, Griffin D, Bali P, O'Bryan E, Fumero C, Wang HG and Bhalla K . (2002). Blood, 99, 3419–3426.

  • Hahne M, Rimoldi D, Schroeter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerrottini J and Tschopp J . (1996). Science, 274, 1363–1366.

  • Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM and Mak TW . (1998). Cell, 94, 339–352.

  • Harper N, Farrow SN, Kaptein A, Cohen GM and MacFarlane M . (2001). J. Biol. Chem., 276, 34743–34752.

  • Hengartner MO . (2000). Nature, 407, 770–777.

  • Hermine O, Haioun C, Lepage E, d'Agay MF, Briere J, Lavignac C, Fillet G, Salles G, Marolleau JP, Diebold J, Reyas F and Gaulard P . (1996). Blood, 87, 265–272.

  • Herr I and Debatin KM . (2001). Blood, 98, 2603–2614.

  • Herr I, Wilhelm D, Bohler T, Angel P and Debatin KM . (1997). EMBO J., 16, 6200–6208.

  • Hill ME, MacLennan KA, Cunningham DC, Vaughan-Hudson B, Burke M, Clarke P, Di-Stefano F, Anderson L, Vaughan-Hudson G, Mason D, Selby P and Linch DC . (1996). Blood, 88, 1046–1051.

  • Hogarth LA and Hall AG . (1999). Blood, 93, 2671–2678.

  • Holcik M and Korneluk RG . (2001). Nat. Rev. Mol. Cell. Biol., 7, 550–556.

  • Houghton JA, Harwood FG and Tillman DM . (1997). Proc. Natl. Acad. Sci. USA, 94, 8144–8149.

  • Hu W and Kavanagh JJ . (2003). The Lancet, 4, 721–729.

  • Hyer ML, Voelkel-Johnson C, Rubinchik S, Dong J and Norris JS . (2000). Mol. Ther., 2, 348–358.

  • Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T, Zhang H, Mountz JD, Koopman WJ, Kimberly RP and Zhou T . (2001). Nat. Med., 7, 954–960.

  • Igney FH, Behrens C and Krammer PH . (2000). Eur. J. Immunol., 30, 725–731.

  • Igney FH and Krammer PH . (2002a). J. Leukocyte Biol., 71, 907–920.

  • Igney FH and Krammer PH . (2002b). Nat. Rev. Cancer, 2, 277–288.

  • Iijima N, Miyamura K, Itou T, Tanimoto M, Sobue R and Saito H . (1997). Blood, 90, 4901–4909.

  • Ionov Y, Yamamoto H, Krajewski S, Reed JC and Perucho M . (2000). Proc. Natl. Acad. Sci. USA, 97, 10872–10877.

  • Janicke RU, Sprengart ML, Wati MR and Porter AG . (1998). J. Biol. Chem., 273, 9357–9360.

  • Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T and Debatin KM . (1998). Blood, 91, 4624–4631.

  • Jiang Y, Woronicz JD, Liu W and Goeddel DV . (1999). Science, 283, 543–546.

  • Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR and Strom SC . (2000). Nat. Med., 6, 564–567.

  • Johnson DE . (2000). Leukemia, 14, 1695–1703.

  • Johnstone RW, Ruefli AA and Lowe SW . (2002). Cell, 108, 153–164.

  • Kamihira S, Yamada Y, Tomonaga M, Sugahara K and Tsuruda K . (1999). Br. J. Haematol., 107, 851–860.

  • Kang SM, Hoffman A, Le D, Spinger LM, Stock PG and Blau HM . (1997a). Science, 278, 1322–1324.

  • Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG and Baekkeskov S . (1997b). Nat. Med., 3, 738–743.

  • Kanwar JR, Shen WP, Kanwar RK, Berg RW and Krissansen GW . (2001). J. Natl. Cancer Inst., 93, 1541–1552.

  • Kapranos N, Karaiosifidi H, Valavanis C, Kouri E and Vasilaros S . (1997). Anticancer Res., 17, 2499–2505.

  • Karin M, Cao Y, Greten FR and Li ZW . (2002). Nat. Rev. Cancer, 2, 301–310.

  • Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A and Green DR . (1998). Mol. Cell, 1, 543–551.

  • Kataoka T, Schroter M, Hahne M, Schneider P, Irmler M, Thome M, Froelich CJ and Tschopp J . (1998). J. Immunol., 161, 3936–3942.

  • Kaufmann SH . (1989). Cancer Res., 49, 5870–5878.

  • Kaufmann SH and Earnshaw WC . (2000). Exp. Cell Res., 256, 42–49.

  • Kaufmann SH and Vaux DL . (2003). Oncogene, 22, 7414–7430.

  • Keane MM, Rubinstein Y, Cuello M, Ettenberg SA, Banerjee P, Nau MM and Lipkowitz S . (2000). Breast Cancer Res. Treat., 64, 211–219.

  • Kinoshita H, Yoshikawa H, Shiiki K, Hamada Y, Nakajima Y and Tasaka K . (2000). Int. J. Cancer, 88, 986–991.

  • Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ and Ashkenazi A . (2000). Immunity, 12, 611–620.

  • Kohler T, Schill C, Deininger MW, Krahl R, Borchert S, Hasenclever D, Leiblein S, Wagner O and Niederwieser D . (2002). Leukemia, 16, 22–29.

  • Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S and Reed JC . (1995a). Cancer Res., 55, 4471–4478.

  • Krajewski S, Chatten J, Hanada M and Reed JC . (1995b). Lab. Invest., 72, 42–54.

  • Krajewski S, Krajewska M, Turner BC, Pratt C, Howard B, Zapata JM, Frenkel V, Robertson S, Ionov Y, Yamamoto H, Perucho M, Takayama S and Reed JC . (1999). Endocr. Relat. Cancer, 6, 29–40.

  • Krajewski S, Thor A, Edgerton SM, Moore II DH, Krajewska M and Reed JC . (1997). Clin. Cancer Res., 3, 199–208.

  • Krammer PH . (2000). Nature, 407, 789–795.

  • Kroemer G and Reed JC . (2000). Nat. Med., 6, 513–519.

  • Kymionis GD, Dimitrakakis CE, Konstadoulakis MM, Arzimanoglou I, Leandros E, Chalkiadakis G, Keramopoulos A and Michalas S . (2001). J. Surg. Res., 99, 161–168.

  • Landowski TH, Moscinski L, Burke R, Buyuksal I, Painter JS, Goldstein S and Dalton WS . (2001). Leukemia Lymphoma, 42, 835–846.

  • Landowski TH, Shain KH, Oshiro MM, Buyuksal I, Painter JS and Dalton WS . (1999). Blood, 94, 265–274.

  • Lassus P, Opitz-Araya X and Lazebnik Y . (2002). Science, 297, 1352–1354.

  • Lau HT, Yu M, Fontana M and Stoeckert Jr CJ . (1996). Science, 273, 109–112.

  • Lauria F, Raspadori D, Rondelli D, Ventura MA, Fiacchini M, Visani G, Forconi F and Tura S . (1997). Leukemia, 11, 2075–2078.

  • Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, Gliniak B, Bussiere J, Smith CA, Strom SS, Kelley S, Fox JA, Thomas D and Ashkenazi A . (2001). Nat. Med., 7, 383–385.

  • LeBlanc HN and Ashkenazi A . (2003). Cell Death Differ., 10, 66–75.

  • Lee HK, Park JY, Oh RR, Han SY, Lee JH, Lee JY and Yoo NJ . (2000). J. Invest. Dermatol., 114, 122–126.

  • Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, Lee JH, Han SY, Park JY, Oh RR, Kang CS, Kim KM, Jang JJ, Nam SW, Lee JY and Yoo NJ . (2001a). Oncogene, 20, 399–403.

  • Lee SH, Shin MS, Kim HS, Park WS, Kim SY, Jang JJ, Rhim KJ, Jang J, Leist M and Jaattela M . (2001b). Nat. Rev. Mol. Cell. Biol., 2, 589–598.

  • Leist M and Jaattela M . (2001). Nat. Rev. Mol. Cell. Biol., 2, 589–598.

  • Leppa S and Bohmann D . (1999). Oncogene, 18, 6158–6162.

  • Leverkus M, Yaar M and Gilchrest BA . (1997). Exp. Cell Res., 232, 255–262.

  • Li J, Feng Q, Kim JM, Schneiderman D, Liston P, Li M, Vanderhyden B, Faught W, Fung MF, Senterman M, Korneluk RG and Tsang BK . (2001a). Endocrinology, 142, 370–380.

  • Li LY, Luo X and Wang X . (2001b). Nature, 412, 95–99.

  • Lopez-Guillermo A, Cabanillas F, McDonnell TI, McLaughlin P, Smith T, Pugh W, Hagemeister F, Rodriguez MA, Romaguera JE, Younes A, Sarris AH, Preti HA and Lee MS . (1999). Blood, 93, 3081–3087.

  • Los M, Wesselborg S and Schulze-Osthoff K . (1999). Immunity, 10, 629–639.

  • Lowe SW . (1995). Curr. Opin. Oncol., 7, 547–553.

  • Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T . (1994). Science, 266, 807–810.

  • Lowe SW and Lin AW . (2000). Carcinogenesis, 21, 485–495.

  • MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM and Alnemri ES . (1997). J Biol. Chem., 272, 25417–25420.

  • Mandruzzato S, Brasseur F, Andry G, Boon T and van der Bruggen P . (1997). J. Exp. Med., 186, 785–793.

  • Marcucci G, Byrd JC, Dai G, Klisovic MI, Kourlas PJ, Young DC, Cataland SR, Fisher DB, Lucas D, Chan KK, Porcu P, Lin ZP, Farag SF, Frankel SR, Zwiebel JA, Kraut EH, Balcerzak SP, Bloomfield CD, Grever MR and Caligiuri MA . (2003). Blood, 101, 425–432.

  • Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM and Strasser A . (2002). Nature, 419, 634–637.

  • Maung ZT, MacLean FR, Reid MM, Pearson AD, Proctor SJ, Hamilton PJ and Hall AG . (1994). Br. J. Haematol., 88, 105–109.

  • Meng RD and El-Deiry WS . (2001). Exp. Cell Res., 262, 154–169.

  • Meng RD, McDonald III ER, Sheikh MS, Fornace Jr AJ and El-Deiry WS . (2000). Mol. Ther., 1, 130–144.

  • Micheau O, Hammann A, Solary E and Dimanche-Boitrel MT . (1999a). Biochem. Biophys. Res. Commun., 256, 603–611.

  • Micheau O, Solary E, Hammann A and Dimanche-Boitrel MT . (1999b). J. Biol. Chem., 274, 7987–7992.

  • Min YH, Lee S and Lee JW . (1996a). Br. J. Haematol., 93, 928–930.

  • Min YH, Lee S, Lee JW, Chong SY, Hahn JS and Ko YW . (1996b). Br. J. Haematol., 93, 928–930.

  • Miyashita T and Reed JC . (1993). Blood, 81, 151–157.

  • Mo YY and Beck WT . (1999). Mol. Pharmacol., 55, 216–222.

  • Morris MJ, Tong WP, Cordon-Cardo C, Drobnjak M, Kelly WK, Slovin SF, Terry KL, Siedlecki K, Swanson P, Rafi M, DiPaola RS, Rosen N and Scher H-I . (2002). Clin. –Cancer Res., 8, 679–683.

  • Mrózek A, Petrowsky H, Sturm I, Kraus J, Hermann S, Hauptmann S, Lorenz M, Dörken B and Daniel PT . (2003). Cell Death Differ., 10, 461–467.

  • Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH and Galle PR . (1997). J. Clin. Invest., 99, 403–413.

  • Muller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M and Krammer PH . (1998). J. Exp. Med., 188, 2033–2045.

  • Muschen M, Rajewsky K, Kronke M and Kuppers R . (2002). Rends. Immunol., 23, 75–80.

  • Nagane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK and Huang HJ . (2000). Cancer Res., 60, 847–853.

  • Nagata S . (2000). Exp. Cell Res., 256, 128.

  • Nakata B, Muguruma K, Hirakawa K, Chung YS, Yamashita Y, Inoue T, Matsuoka T, Onoda N, Kato Y and Sowa M . (1998). Oncology, 55, 543–547.

  • Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U and Zipp F . (2000). Lancet, 356, 827–828.

  • O'Connell J, O'Sullivan GC, Collins JK and Shanahan F . (1996). J. Exp. Med., 184, 1075–1082.

  • Olie RA, Hafner C, Kuttel R, Sigrist B, Willers J, Dummer R, Hall J, Stahel RA and Zangemeister-Wittke U . (2002). J. Invest. Dermatol., 118, 505–512.

  • Olsson A, Diaz T, Aguilar-Santelises M, Osterborg A, Celsing F, Jondal M and Osorio LM . (2001). Leukemia, 15, 1868–1877.

  • Ong YL, McMullin MF, Bailie KE, Lappin TR, Jones FG and Irvine AE . (2000). Br. J. Haematol., 111, 182–189.

  • Ozoren N and El-Deiry WS . (2003). Semin. Cancer Biol., 13, 135–147.

  • Pai SI, Wu GS, Ozoren N, Wu L, Jen J, Sidransky D and El-Deiry WS . (1998). Cancer Res., 58, 3513–3518.

  • Pan G, Ni J, Wei YF, Yu G, Gentz R and Dixit VM . (1997a). Science, 277, 815–818.

  • Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J and Dixit VM . (1997b). Science, 276, 111–113.

  • Park WS, Lee JH, Shin MS, Park JY, Kim HS, Kim YS, Park CH, Lee SK, Lee SH, Lee SN, Kim H, Yoo NJ and Lee JY . (2001a). Gastroenterology, 121, 1219–1225.

  • Park WS, Lee JH, Shin MS, Park JY, Kim HS, Lee JH, Kim YS, Lee SN, Xiao W, Park CH, Lee SH, Yoo NJ and Lee JY . (2002). Oncogene, 21, 2919–2925.

  • Park WS, Oh RR, Kim YS, Park JY, Lee SH, Shin MS, Kim SY, Kim PJ, Lee HK, Yoo NY and Lee JY . (2001b). J. Pathol., 193, 162–168.

  • Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S and Pagliuca A . (2000). Blood, 96, 3932–3938.

  • Pezzella F, Jones M, Ralfkiaer E, Ersboll J, Gatter KC and Mason DY . (1992). Br. J. Cancer, 65, 87–89.

  • Piris MA, Pezzella F, Martinez-Montero JC, Orradre JL, Villuendas R, Sanchez-Beato M, Cuena R, Cruz MA, Martinez B and Pezzella F . (1994). Br. J. Cancer, 69, 337–341.

  • Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D and Ashkenazi A . (1998). Nature, 396, 699–703.

  • Plumas J, Jacob MC, Chaperot L, Molens JP, Sotto JJ and Bensa JC . (1998). Blood, 91, 2875–2885.

  • Poulaki V, Mitsiades CS and Mitsiades N . (2001). Drug Resist. Updat., 4, 233–242.

  • Prokop A, Wieder T, Sturm I, Essmann F, Seeger K, Wuchter C, Ludwig WD, Henze G, Dorken B and Daniel PT . (2000). Leukemia, 14, 1606–1613.

  • Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC and Perucho M . (1997). Science, 275, 967–969.

  • Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Viviani S, Bonfante V, Nadali G, Herling M, Angelopoulou MK, Giardini R, Chilosi M, Kittas C, McDonnell TJ, Bonadonna G, Gianni AM, Pizzolo G, Pangalis GA, Cabanillas F and Sarris AH . (2002). Blood, 100, 3935–3941.

  • Rau B, Sturm I, Lage H, Berger S, Schneider U, Hauptmann S, Wust P, Riess H, Schlag PM, Dörken B and Daniel PT . (2003). J. Clin. Oncol., 21, 3391–3401.

  • Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gelinas C, Fuchs EJ and Bedi A . (2001). Nat. Cell Biol., 3, 409–416.

  • Reap EA, Roof K, Maynor K, Borrero M, Booker J and Cohen PL . (1997). Proc. Natl. Acad. Sci. USA, 94, 5750–5755.

  • Reed JC . (1997). Adv. Pharmacol., 41, 501–532.

  • Reed JC . (1996). J.Clin. Invest., 97, 2403–2404.

  • Reed JC . (1999). J. Clin. Oncol., 17, 2941–2953.

  • Rehemtulla A, Hamilton CA, Chinnaiyan AM and Dixit VM . (1997). J. Biol. Chem., 272, 25783–25786.

  • Restifo NP . (2001). Nat. Med., 7, 259.

  • Rich T, Allen RL and Wyllie AH . (2000). Nature, 407, 777–783.

  • Robertson LE, Plunkett W, McConnell K, Keating MJ and McDonnell TJ . (1996). Leukemia, 10, 456–459.

  • Rochaix P, Krajewski S, Reed JC, Bonnet F, Voigt JJ and Brousset P . (1999). J. Pathol., 187, 410–415.

  • Rohn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H and Weller M . (2001). Oncogene, 20, 4128–4137.

  • Roninson IB, Broude EV and Chang BD . (2001). Drug Resist. Updat., 4, 303–313.

  • Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Monserrat E, Lopez-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stoke T and Staudt LM . (2002). N. Engl. J. Med., 346, 1937–1947.

  • Roy S and Nicholson DW . (2000). J. Exp. Med., 192, 21–26.

  • Rudin CM, Otterson GA, Mauer AM, Villalona-Calero MA, Tomek R, Prange B, George CM, Szeto L and Vokes EE . (2002). Ann. Oncol., 13, 539–545.

  • Salvesen GS and Duckett CS . (2002). Nat. Rev. Mol. Cell. Biol., 3, 401–410.

  • Samali A, Cai J, Zhivotovsky B, Jones DP and Orrenius S . (1999). EMBO J., 18, 2040–2048.

  • Samowitz WS, Curtin K, Neuhausen S, Schaffer D and Slattery ML . (2002). Genes. Chromosomes Cancer, 35, 368–371.

  • Satomi D, Takiguchi N, Koda K, Oda K, Suzuki H, Yasutomi J, Ishikura H and Miyazaki M . (2002). Int. J. Oncol., 20, 1167–1171.

  • Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME . (1998). EMBO J., 17, 1675–1687.

  • Schelwies K, Sturm I, Grabowski P, Scherbl H, Süchindler I, Hermann S, Stein H, Buhr HJ, Riecken EO, Zeitz M, Dörken B and Daniel PT . (2002). Int. J. Cancer, 99, 589–596.

  • Schimmer AD, Munk-Pedersen I, Minden MD and Reed JC . (2003). Curr. Treat. Options Oncol., 4, 211–218.

  • Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N and Tschopp J . (1997). Immunity, 7, 831–836.

  • Schriever F and Dorken B . (2001). Lancet, 2, 33–42.

  • Shin MS, Kim HS, Kang CS, Park WS, Kim SY, Lee SN, Lee JH, Park JY, Jang JJ, Kim CW, Kim SH, Lee JY, Yoo NJ and Lee SH . (2002a). Blood, 99, 4094–4099.

  • Shin MS, Kim HS, Lee SH, Lee JW, Song YH, Kim YS, Park WS, Kim SY, Lee SN, Park JY, Lee JH, Xiao W, Jo KH, Wang YP, Lee KY, Park YG, Kim SH, Lee JY and Yoo NJ . (2002b). Oncogene, 21, 4129–4136.

  • Shin MS, Kim HS, Lee SH, Park WS, Kim SY, Park JY, Lee JH, Lee SK, Lee SN, Jung SS, Han JY, Kim H, Lee JY and Yoo NJ . (2001). Cancer Res., 61, 4942–4946.

  • Sjostrom J, Blomqvist C, von Boguslawski K, Bengtsson NO, Mjaaland I, Malmstrom P, Ostenstadt B, Wist E, Valvere V, Takayama S, Reed JC and Saksela E . (2002). Clin. Cancer Res., 8, 811–816.

  • Sjostrom J, Krajewski S, Franssila K, Niskanen E, Wasenius VM, Nordling S, Reed JC and Blomqvist C . (1998). Br. J. Cancer, 78, 812–815.

  • Slee EA, Adrain C and Martin SJ . (1999). Cell Death Differ., 6, 1067–1074.

  • Solary E, Droin N, Bettaieb A, Corcos L, Dimanche-Boitrel MT and Garrido C . (2000). Leukemia, 14, 1833–1849.

  • Sperandio S, de Belle I and Bredesen DE . (2001). Proc. Natl. Acad. Sci. USA, 7, 14376–14381.

  • Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH and Walczak H . (2000). Immunity, 12, 599–609.

  • Srinivasula SM, Ahmad M, Guo Y, Zhan Y, Lazebnik Y, Fernandes-Alnemri T and Alnemri ES . (1999). Cancer Res., 59, 999–1002.

  • Stahnke K, Eckhoff S, Mohr A, Meyer LH and Debatin KM . (2003). Leukemia, 17, 2130–2139.

  • Stahnke K, Fulda S, Friesen C, Strauss G and Debatin KM . (2001). Blood, 98, 3066–3073.

  • Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH and Galle PR . (1996). Nat. Med., 2, 1361–1366.

  • Sturm I, Kohne Ch., Wolff G, Petrowsky H, Hillebrand T, Hauptmann S, Lorenz M, Dörken B and Daniel PT . (1999). J. Clin. Oncol., 17, 1364–1374.

  • Sturm I, Petrowsky H, Volz R, Lorenz M, Radetzky S, Hillebrand T, Wolff G, Hauptmann S, Dörken B and Daniel PT . (2001). J. Clin. Oncol., 19, 2272–2281.

  • Susin SA, Lorenzo HK, Zamzami N, Marzo I, Brenner C, Larochette N, Prevost MC, Alzari PM and Kroemer G . (1999). J. Exp. Med., 189, 381–394.

  • Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K and Takahashi R . (2000). Mol. Cell, 8, 613–621.

  • Svingen PA, Karp JE, Krajewski S, Mesner Jr PW, Gore SD, Burke PJ, Reed JC, Lazebnik YA and Kaufmann SH . (2000). Blood, 96, 3922–3931.

  • Takakawa T, Dong Z, Takayama H, Matsuzaka F, Nagata S and Aozasa K . (2001). Cancer Res., 15, 1382–1385.

  • Takayama H, Takakuwa T, Tsujimoto Y, Tani Y, Nonomura N, Okoyama A, Nagata S and Aozasa K . (2002). Am. J. Pathol., 161, 635–641.

  • Takimoto R and El-Deiry WS . (2000). Oncogene, 19, 1735–1743.

  • Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M and Reed JC . (2000). Clin. Cancer Res., 6, 1796–1803.

  • Tamm I, Trepel M, Cardo-Vila M, Sun Y, Welsh K, Cabezas E, Swatterhwait A, Arap W, Reed JC and Pasqualini R . (2003). J. Biol. Chem., 278, 14401–14405.

  • Tang D, Lahti JM and Kidd VJ . (2000). J. Biol. Chem., 275, 9303–9307.

  • Teitz T, Wie T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM and Kidd VJ . (2000). Nat. Med., 6, 529–535.

  • ten Berge RL, Meijer CJ, Dukers DF, Kummer JA, Bladergroen BA, Vos W, Hack CE, Ossenkoppele GJ and Oudejans JJ . (2002). Blood, 99, 4540–4546.

  • Tepper CG and Seldin MF . (1999). Blood, 94, 1727–1737.

  • Thornberry N and Lazebnik Y . (1998). Science, 281, 1312–1316.

  • Tschopp J, Irmler M and Thome M . (1998). Curr. Opin. Immunol., 10, 552–558.

  • Tsurusawa M, Saeki K, Katano N, Fujimoto T and Children's Cancer Leukemia Study Group. (1998). Pediatr. Hematol. Oncol., 15, 143–155.

  • Utz PJ and Anderson P . (2000). Cell Death Differ., 7, 589–602.

  • Vakkala M, Lahteenmaki K, Raunio H, Paakko P and Soini Y . (1999). Clin. Cancer Res., 5, 319–324.

  • van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ and Vandenabeele P . (2002). Cell Death Differ., 9, 1031–1042.

  • van Noesel MM, van Bezouw S, Salomons GS, Voute PA, Pieters R, Baylin SB, Herman JG and Versteeg R . (2002). Cancer Res., 62, 2157–2161.

  • Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P and Wallach D . (1998). Immunity, 9, 267–276.

  • Vassallo J, Metze K, Traina F, de Souza CA and Lorand-Metze I . (2003). Leukemia Lymphoma, 44, 483–488.

  • Veronese S, Mauri FA, Caffo O, Scaioli M, Aldovini D, Perrone G, Galligioni E, Doglioni C, Dalla-Palma P and Barbareschi M . (1998). Int. J. Cancer, 79, 13–18.

  • Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R and Greil R . (1997a). Cancer Res., 57, 3331–3333.

  • Villunger A, Egle A, Marschitz I, Kos M, Bock G, Ludwig H, Geley S, Kofler R and Greil R . (1997b). Blood, 90, 12–20.

  • Villunger A and Strasser A . (1999). Nat. Med., 5, 874–875.

  • Wajant H, Pfizenmaier K and Scheurich P . (2002). Apoptosis, 7, 449–459.

  • Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG and Rauch CT . (1997). EMBO J., 16, 5386–5397.

  • Walczak H and Krammer PH . (2000). Exp. Cell Res., 256, 58–66.

  • Walczak H, Miler RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH . (1999). Nat. Med., 5, 157–163.

  • Wang L, Miura M, Bergeron L, Zhu H and Yuan J . (1994). Cell, 78, 739–750.

  • Waters JS, Webb A, Cunningham D, Clarke PA, Raynaud F, di-Stefano F and Cotter FE . (2000). J. Clin. Oncol., 8, 1812–1823.

  • Webb A, Cunningham D, Cotter F, Clarke PA, di-Stefano F, Ross P, Corbo M and Dziewanowska Z . (1997). Lancet, 349, 1137–1141.

  • Wendum D, Sebban C, Gaulard P, Coiffier B, Tilly H, Cazals D, Boehn A, Casasnovas RO, Bouabdallah R, Jaubert J, Ferrant A, Diebold J, de-Mascarel A, Gisselbrecht C and Groupe d'Etude des Lymphomes de l'Adulte. (1997). J. Clin. Oncol., 15, 1654–1663.

  • Wesselborg S, Engels IH, Rossmann E, Los M and Schulze-Osthoff K . (1999). Blood, 93, 3053–3063.

  • Whang-Peng J, Knutsen T, Jaffe ES, Steinberg SM, Raffeld M, Zhao WP, Duffey P, Condron K, Yano T and Longo DL . (1995). Blood, 85, 203–216.

  • Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C and Smith CA . (1995). Immunity, 3, 673–682.

  • Wu GS, Burns TF, McDonald III ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G and el-Deiry WS . (1997). Nat. Genet., 17, 141–143.

  • Wuchter C, Karawajew L, Ruppert V, Buchner T, Schoch C, Haferlach T, Ratei R, Dorken B and Ludwig WD . (1999a). Leukemia, 13, 1943–1953.

  • Wuchter C, Karawajew L, Ruppert V, Buchner T, Schoch C, Haferlach T, Ratei R, Dorken B, Ludwig WD, Hogarth LA and Hall G . (1999b). Blood, 93, 2671–2678.

  • Wuchter C, Karawajew L, Ruppert V, Schrappe M, Harbott J, Ratei R, Dorken B and Ludwig WD . (2000). Br. J. Haematol., 110, 154–160.

  • Xia C, Xu Z, Yuan X, Uematsu K, You L, Li K, Li L, McCormick F and Jablons DM . (2002). Mol. Cancer Ther., 1, 687–694.

  • Yamamoto H, Perez-Piteira J, Yoshida T, Terada M, Itoh F, Imai K and Perucho M . (1999). Gastroenterology, 116, 1348–1357.

  • Yang E and Korsmeyer SJ . (1996). Blood, 88, 386–401.

  • Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-Hara T and Tsuruo T . (2003). Cancer Res., 63, 831–837.

  • Yang XH, Sladek TL, Liu X, Butler BR, Froelich CJ and Thor AD . (2001). Cancer Res., 61, 348–354.

  • Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV and Mak TW . (1998). Science, 279, 1954–1958.

  • Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM and Mak TW . (1998). Cell, 94, 739–750.

  • Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA and Zangemeister-Wittke U . (1997). J. Natl. Cancer. Inst., 89, 1027–1036.

Download references

Acknowledgements

We thank Violetta Krok for excellent secretarial assistance. Work in the authors laboratories is supported by grants from the European Union, Bundesministerium für Forschung und Technologie, Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, Deutsche Kinderkrebsstiftung, Else-Kröner-Fresenius-Stiftung and Wilhelm-Sander-Stiftung.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Klaus-Michael Debatin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Debatin, KM., Krammer, P. Death receptors in chemotherapy and cancer. Oncogene 23, 2950–2966 (2004). https://doi.org/10.1038/sj.onc.1207558

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207558

Keywords

This article is cited by

Search

Quick links